|
|
|
|
Questions raised over diabetes tests
CHILDREN with diabetes are not getting all the care they should have in the county, according to a new report.But the Norfolk and Norwich University Hospital says that it is giving young people the recommended care - just that keeping all...
|
|
|
EU Sanctions Novartis Drug for Steroid-Induced Osteoporosis
Novartisbisphosphonate infusion, Aclasta, received approval in the EU for the treatment of men and postmenopausal women with osteoporosis caused by long-term glucocorticoid therapy.The drug is already marketed in the U.S. for this...
|
|
|
Four people in hospital after crash
Four people were taken to the James Paget University Hospital after a crash on the Acle Straight.The accident happened at about 12. Four people in hospital after crash.
|
|
|
Emerging treatments for postmenopausal osteoporosis – focus on denosumab
Clinical Interventions in Aging, 06/08/09 Geusens P - The pathway of the receptor activator of the nuclear factor ?B ligand (RANKL), RANK and osteoprotegerin (OPG) plays a central role in coupling bone formation and resorption during...
|
|
|
Finance chief leaves Ipswich Hospital
IPSWICH Hospital's finance and performance chief has quit the hospital.Mark Madden, director of finance and performance, will leave the trust in September and move to the James Paget Hospital in Gorleston, taking on the same role.
|
|
|
New finance director for hospital
A hospital trust in Norfolk has announced the appointment of a new director of finance and performance.Mark Madden, currently director of finance at the Ipswich Hospital NHS Trust, will take up the new post at the James Paget...
|
|
|
Hospital offers new digital breast screening service
A Norfolk hospital has become the first in the East of England to offer a fully digital breast screening service using technology that provides crystal clear images making it easier for cancers to be spotted.The new equipment at James ...
|
|
|
FDA approved zoledronic acid injection to treat postmenopausal osteoporosis
The FDA approved zoledronic acid injection as the first therapy to treat postmenopausal osteoporosis for two years with a single dose.Zoledronic acid injection was previously approved as a once-yearly infusion to treat postmenopausal...
|
|
|
Events will aid cancer centre
A SERIES of fundraising events have been organised over a two week period to raise money for the Sandra Chapman Centre at James Paget University Hospital.The fortnight of fun is taking place at Cobholm Community Centre and will...
|
|
|
Novartis, GSK meds get expanded indications
The FDA has approved Novartis' osteoporosis drug Reclast for an expanded indication.Currently approved as a once-yearly infusion to treat post-menopausal osteoporosis, the drug will now also be marketed as a single treatment for use once...
|
|
|
Novartis osteoporosis drug approved in U.S
EAST HANOVER, N.J.(Jun. 1) The Food and Drug Administration as approved Reclast (zoledronic acid) injection for the prevention of postmenopausal osteoporosis for two years with a single dose, Novartis Pharmaceuticals announced Monday.
|
|
|
FDA approves less frequent dosage for Reclast
EAST HANOVER, N.J.(Jun. 1) The Food and Drug Administration approved the Reclast (zoledronic acid) for injection to prevent postmenopausal osteoporosis for two years with a single dose. The once annual injection was used to treat...
|
|
|
Novartis' Osteoporosis Drug Gets FDA Okay for Preventing Postmenopausal Osteoporosis
FDA approved Novartis Reclast(r) as the first two-yearly treatment for the prevention of postmenopausal osteoporosis.The agency based its approval on the results of a study in over 500 postmenopausal women with osteopenia, which showed...
|
|
|
Discovery Of Faulty Genes Could Reveal Risk Of Bone Disease
The discovery of faulty genes by Edinburgh researchers could help people with Paget's disease, a painful bone condition.Dr Omar Albagha has found three genes associated with the disease which, if detected early enough in...
|
|
|
Three faulty genes found to be possible cause of painful bone disease
SCOTLAND (May28) Researchers at University of Edinburgh announced that they have discovered three defective genes that could help people suffering from a painful bone disease known at Pagets disease.Edinburgh researchers...
|
|
|
Discovery Of Faulty Genes Could Reveal Risk Of Bone Disease
The discovery of faulty genes by Edinburgh researchers could help people with Pagets disease, a painful bone condition.Dr Omar Albagha has found three genes associated with the disease which, if detected early enough in people...
|
|
|
Family Doctor: Nonhealing breast lesion could be cancer
Q: I am a retired surgeon who reads your column almost every day.I find it interesting and informative, and I commend you for the service you render to a large number of readers. However, a recent column of Feb. 21 contained...
|
